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Abstract
Background: Improving the lifestyle of overweight and obese adults is of increasing interest in view of its role in
several chronic diseases. Interventions aiming at overweight or weight-related chronic diseases suffer from high
drop-out rates. It has been suggested that Motivational Interviewing and more frequent and more patient-specific
coaching could decrease the drop-out rate. ‘BeweegKuur’ is a multidisciplinary lifestyle intervention which offers
three programmes for overweight persons. The effectiveness and the cost-effectiveness of intensively guided
programmes, such as the ‘supervised exercise programme’ of ‘BeweegKuur’, for patients with high weight-related
health risk, remain to be assessed. Our randomized controlled trial compares the expenses and effects of the
‘supervised exercise programme’ with those of the less intensively supervised ‘start-up exercise programme’.
Methods/Design: The one-year intervention period involves coaching by a lifestyle advisor, a physiotherapist and
a dietician, coordinated by general practitioners (GPs). The participating GP practices have been allocated to the
interventions, which differ only in terms of the amount of coaching offered by the physiotherapist. Whereas the
‘start-up exercise programme’ includes several consultations with physiotherapists to identify barriers hampering
independent exercising, the ‘supervised exercise programme’ includes more sessions with a physiotherapist,
involving exercise under supervision. The main goal is transfer to local exercise facilities. The main outcome of the
study will be the participants’ physical activity at the end of the one-year intervention period and after one year of
follow-up. Secondary outcomes are dietary habits, health risk, physical fitness and functional capacity. The
economic evaluation will consist of a cost-effectiveness analysis and a cost-utility analysis. The primary outcome
measures for the economic evaluation will be the physical activity and the number of quality-adjusted life years.
Costs will be assessed from a societal perspective with a time horizon of two years. Additionally, a process
evaluation will be used to evaluate the performance of the intervention and the participants’ evaluation of the
intervention.
Discussion: This study is expected to provide information regarding the additional costs and effects of the
‘supervised exercise programme’ in adults with very high weight-related health risk.
Trial registration number: ISRCTN: ISRCTN46574304
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The increasing prevalence of overweight and obesity is a
major problem in Western countries. People who are
overweight are at higher risk of developing type 2 diabetes
mellitus, cardiovascular disease and certain types of cancer
[1]. In addition, their health-related quality of life
d e c r e a s e sd u et ot h eo v e r w e i g h ta ss u c ha sw e l la st o
related comorbidities [2]. In the Netherlands, 42% of
women and 53% of men are overweight (BMI > 25 kg/m
2),
of which 12% and 11% respectively are obese (BMI >
30 kg/m
2) [3]. Health care expenses caused by overweight
in the Netherlands amounted to half a billion Euros in
1999 [4].
Not only overweight but also physical inactivity have
been associated with chronic diseases like type 2 dia-
betes and cardiovascular disease [5-7]. Intervening in
people’s lifestyles could help decrease the severity of
chronic diseases and the risk of developing them. Com-
bined lifestyle interventions aimed at increasing physical
activity and improving dietary behaviour have been
shown to have positive effects on metabolic and cardio-
vascular risk factors (e.g. weight, waist circumference,
fat mass, HDL-cholesterol and triglyceride values and
blood pressure) in persons at risk for developing chronic
diseases [8-13], as well as in patients who have already
developed type 2 diabetes [14-17]. Beneficial effects are
still evident after a follow-up period of several years
[7,8].
Recently, a multidisciplinary combined lifestyle inter-
vention for type 2 diabetes patients, called ‘BeweegKuur’,
has been developed by the Netherlands Institute for
Sport and Physical Activity (NISB) [18,19]. Its target
population currently also comprises overweight and
obese patients. The primary goal of the ‘BeweegKuur’
interventions is to improve physical activity and dietary
behaviour and thereby decrease health risks. A recent
study reported, however, that the adherence to exercise
intervention programmes varies widely, from 10% to 80%
[20]. The main causes of drop-out are exercise-related
injuries and motivational factors [14]. It seems likely,
therefore, that the use of Motivational Interviewing
[20,21] and the individualization of the ‘BeweegKuur’
programmes would result in lower drop-out rates. In
addition, it has been proposed to have practice nurses
play a key role in the adoption of long-term behavioural
change by providing this individualized guidance in the
primary health care setting [9,22]. In the ‘BeweegKuur’
programmes, the participant’s behavioural change is sup-
ported by a team consisting of a general practitioner
(GP), a lifestyle advisor (LSA), a physiotherapist and a
d i e t i c i a n .T h eL S A( w h om a yb eap r a c t i c en u r s eo ra
physiotherapist) has the key role in this multidisciplinary
team and offers wide-ranging lifestyle counselling aimed
at promoting physical activity, improving diet and redu-
cing psychological barriers by means of Motivational
Interviewing [21]. A physiotherapist provides coaching
for physical activity to enable participants to transfer to
local exercise facilities, and a dietician provides advice on
dietary improvement. The use of the ‘BeweegKuur’ pro-
grammes in primary care has proved to be feasible, as
health care providers as well as participants are very posi-
tive about the programmes after having implemented it
[23,24].
Care providers using ‘BeweegKuur’ offer three pro-
grammes, differing in the amount of support. The ‘inde-
pendent exercise programme’ is intended for overweight
and obese individuals without comorbidities, while the
‘start-up exercise programme’ and the ‘supervised exercise
programme’ are both intended for adults with overweight
or obesity who suffer from comorbidities or are morbidly
obese. An earlier study showed that the amount of support
required to achieve lifestyle changes increases with the
severity of overweight and the presence of comorbidities
[9]. Additionally, the number of feedback sessions is
believed to be positively related to programme adherence
[20]. Hence, the ‘supervised exercise programme’ involves
more coaching by the physiotherapist.
Less intensively supervised programmes have been
shown to be effective and cost-effective for people with
type 2 diabetes or an increased risk of developing type 2
diabetes [8,13,17]. The effectiveness and cost-effectiveness
of intensively supervised programmes for a population
with very high weight-related health risk remain to be stu-
died. Therefore, our randomized controlled trial aims to
evaluate the effects of the ‘supervised exercise programme’,
in terms of the amount of physical activity and related
health risks, and its cost-effectiveness, compared to those
of the ‘start-up exercise programme’, for this population.
The time horizon of the study will be two years. The eco-
nomic evaluation will involve cost-effectiveness and cost-
utility analyses from a societal perspective. In addition, a
process evaluation is planned.
Methods/Design
Study design
The present study is a clustered, multi-centre, rando-
mized controlled trial evaluating the effectiveness and
cost-effectiveness of the ‘supervised exercise programme’
versus the less intensively supervised ‘start-up exercise
programme’ for patients with very high weight-related
health risk. Thirty Dutch GP practices, each collaborating
with a practice nurse, a physiotherapist and a dietician,
have been randomly assigned to the control or experi-
mental condition. In experimental practices, participants
will take part in the ‘supervised exercise programme’,
while participants in a control practice will take part in
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measurements take place at baseline, after 12 months
(the end of the intervention period) and after 24 months
(Figure 1). In addition, self-administered questionnaires
comprising cost-, effect- and process-related outcome
measures will be sent to the participants every three
months.
This study is approved by the Medical Ethics Committee
of the Maastricht University Medical Centre and is regis-
tered with Current Controlled Trials (ISRCTN46574304).
The study is funded by The Netherlands Organization for
Health Research and Development (ZonMW; project
number: 123000002).
Randomization
To reduce the risk of contamination between participants,
and the risk of bias at the level of the professionals
involved, entire practices have been allocated to the con-
trol or experimental condition. Prior to randomization, all
practices have been matched pair wise based on size and
location in an urban or rural area, to create two equivalent
samples of 15 practices. In each pair, one practice has
been randomized to the control condition, while the other
was randomized to the experimental condition. To reduce
the risk of contamination within a region, practices in the
same region were allocated to the same condition as the
first practice in that region that was randomized.
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Figure 1 Flowchart of the ‘BeweegKuur’ randomized controlled trial and measurements. A. Health care utilisation and productivity losses,
EQ5-D and process items in questionnaire every three months; B. Clinical outcomes measured in questionnaire every six months; C. Clinical
outcome measurements performed every year. Table 2 shows outcomes in each category. T0-T24 represent moments of measurement. T0 =
Baseline; T3 = Three months after baseline; T6 = Six months after baseline; ...; T24 = 24 months after baseline.
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Inclusion of participants started in July 2010. Inclusion cri-
teria are (1) being overweight or obese (BMI 25-35 kg/m
2)
combined with the following serious related comorbidities:
sleep apnoea, arthritis, cardiovascular disease and/or type
2 diabetes; or (2) being morbidly obese (BMI 35-40 kg/m
2)
but without these related serious comorbidities. In addi-
tion, participants should currently fail to meet the Dutch
norm for healthy physical activity (30 minutes of moderate
to vigorous physical activity on at least 5 days a week),
have to be sufficiently motivated to change their physical
activity level and dietary behaviour (to be judged subjec-
tively by the LSA during intake) and have to give their
informed consent.
Participants are being included via GPs, practice nurses
and physiotherapists. The GP, practice nurse or phy-
siotherapist selects patients by discussing the intervention
during a consultation. However, they can also recruit
patients actively (e.g. by searching the health care provi-
der’s records). The LSA screens the patients for eligibility.
Exclusion criteria are serious mobility limitations preclud-
ing participation in the intervention programme, such as
severe cardiac failure, serious angina pectoris and rheuma-
toid arthritis. Pregnancy is also an exclusion criterion. The
GP decides whether patients should be excluded.
Blinding
Although it is not possible to blind the professionals, ran-
domization at the level of GP practices decreases the risk
of contamination among the professionals. Participants
are not aware of the allocation of their practice to the
experimental or control condition.
To identify effects of observer bias, clinical measure-
ments that might be affected (Åstrand test, Valk neuropa-
thy test, body composition, hand grip strength and Timed
Up and Go Test) will be repeated by a researcher blinded
for the randomization of the practices and the baseline
characteristics of the participants. Repeated measurements
will be done for 20 participants in five randomly chosen
control and five randomly chosen experimental practices.
Intervention
After inclusion, participants have several consultations
with the LSA, dietician and physiotherapist during a one-
year intervention period. The number of consultations
differs per programme (table 1).
Experimental intervention (‘supervised exercise programme’)
The LSA has a key role in supporting the participants and
is the point of contact between the participants and the
other health care providers in the ‘BeweegKuur’ pro-
gramme. Following an individual intake to set personal
goals, participants will have five individual consultations
with the LSA to discuss progress in terms of behavioural
change, roughly once every 10 weeks, during the one-year
intervention period. Consultations with the dietician will
consist of nutritional recommendations, education, coping
with high-risk situations, checking dietary behaviour and
fellow-sufferer contact. Advice will be based on various
Dutch guidelines for diabetes, overweight and obesity
[25-27]. After an individual intake session by the dietician,
seven group sessions are planned. The group meetings
comprise guidance and advice by the dietician and are
scheduled throughout the year. In addition, two individual
follow-up meetings are planned during the intervention
period to prevent relapse.
The physiotherapist will provide coaching to enable
participants to exercise unsupervised in local exercise
facilities. Coaching by the physiotherapist will be
initiated by setting out personal goals and identifying
barriers hampering engagement in physical activity.
Table 1 Contents and number of consultations planned in the control and experimental interventions
Experimental intervention: Control intervention:
the ‘supervised exercise programme’ the ‘start-up exercise programme’
Contents of LSA consultations No. of meetings Contents of LSA consultations No. of meetings
Intake 1 Intake 1
Guidance and follow-up 5 Guidance and follow-up 5
Contents of dietician consultations No. of meetings Contents of dietician consultations No. of meetings
Intake 1 Intake 1
Guidance and follow-up Guidance and follow-up
- Individual 2 - Individual 2
- Group 7 - Group 7
Contents of physiotherapist consultations No. of meetings Contents of physiotherapist consultations No. of meetings
Intake 1 Intake 1
Setting up exercise plan 2 Setting up exercise plan 1
Supervised exercise 26 - 34 Follow-up 4
Follow-up 3 - 4
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any barriers identified and increase physical capacity.
Two or three sessions of supervised exercise per week
will be planned over a period of 12 weeks. After these
12 weeks, the physiotherapist will evaluate whether the
participant is able to exercise without supervision. The
coaching period can be extended by four weeks if the
participant does not seem able to exercise independently
in local facilities. In all, the physiotherapist’s coaching
will take 12 to 16 weeks. After coaching by the phy-
siotherapist has ended, the five follow-up consultations
with the LSA and three or four follow-up consultations
with the physiotherapist are planned, to help partici-
pants adopt and continue independent exercise activ-
ities. Both the LSA and the physiotherapist will help the
participant find suitable existing exercise facilities during
the entire intervention period.
Control intervention (’start-up exercise programme’)
The number of consultations and the characteristics of the
guidance provided by the LSA and the dietician in
the control condition are the same as in the experimental
condition. However, participants of the ‘start-up exercise
programme’ will only have six consultations with the phy-
siotherapist, which are planned during the first two
months of the intervention period. The consultations with
the physiotherapist consist of identifying barriers to physi-
cal activity and drawing up a plan to remain physically
active without supervision by health care providers. If
deemed necessary by the physiotherapist, participants can
exercise under supervision during these meetings to over-
come barriers to physical activity. Progress and complica-
tions relating to the exercise plan will be discussed in
consultations with the physiotherapist from approximately
two months after the start of the intervention. Addition-
ally, participants will be coached in the adoption and
maintenance of independent exercise activities during the
five follow-up consultations with the LSA during and after
the two months of guidance by the physiotherapist.
Outcomes
Clinical assessments will be done by the ‘BeweegKuur’
health care providers (LSA or physiotherapist) in their
own practice. After the baseline measurement, three dif-
ferent measurement intervals will be used, depending on
the variable to be measured: (A) 3 months, (B) 6 months
and (C) 12 months (figure 1 and table 2).
Physical activity
The primary outcome of this study will be the amount of
physical activity that participants engage in, as measured
by means of accelerometry and the short version of the
International Physical Activity Questionnaire (IPAQ).
The IPAQ short form will be included in the participants’
questionnaire every six months, and consists of questions
concerning the time spent on physical activity at specific
intensities and the number of days on which this hap-
pened. Median values of activity categories will be calcu-
lated and expressed as metabolic equivalent (MET)
minutes per week. The self-administered IPAQ short
form has been reported to be sufficiently valid and reli-
able for use in developed countries [28].
Accelerometry offers an objective way to assess physical
activity. The CAM is a tri-axial accelerometer developed
and manufactured by Maastricht Instruments. The CAM
software is able to distinguish between sedentary beha-
viour, standing and activity, and has been validated for
adults in laboratory conditions [29]. The device weighs
approximately 100 g (63 × 45 × 18 mm) and its sampling
frequency is 25 Hz. Participants will wear the CAM for
four consecutive days; data from waking up until going to
sleep will be used for analysis. Because the CAM is not
waterproof, participants will have to remove the CAM for
swimming, showering, bathing etc. and will be asked to
write down their activities in a diary for such non-wearing
intervals. The main outcomes of the CAM measurements
will be the amount of moderate to vigorous physical activ-
i t y( M V P A )a n dt h ea m o u n to ft i m es p e n ts e d e n t a r y ,
standing or active.
Dietary habits
The short version of the Fat Food questionnaire will be
included in the questionnaire sent to the participants
every six months [30]. The length of this validated Fat
Food questionnaire has been reduced to maximize the
number of questions completed. Twenty-one items
address the respondent’s regular eating pattern (e.g. con-
sumption of vegetables, lettuce and fruit) and consump-
tion of high-fat meals (e.g. take-away food), snacks and
candy.
Risk factors for comorbidities
Body composition (weight, fat mass and fat-free mass)
will be measured with a tetrapolar bioelectrical
Table 2 Type of outcomes in each measurement category (time intervals are shown in figure 1)
A. Costs, utility and process assessment (self-
administered questionnaires)
B. Clinical outcomes (self-administered
questionnaires)
C. Clinical outcomes (measurements by
professionals)
- Health care use, other expenses and productivity losses - Physical activity - Physical activity by accelerometry
- Quality of life - Dietary behaviour - Risk factors for comorbidities
- Process evaluation - Physical fitness
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be taken to analyse fasting glucose (mmol/L), HbA1c (%
or mmol/L), total cholesterol (mmol/L), HDL (mmol/L),
triglycerides (mmol/L) and creatinin (μmol/L). Systolic
and diastolic blood pressure, resting heart rate and BMI
will also be measured.
Physical fitness
Peripheral neuropathy is related to functional capacity in
type 2 diabetes patients [31]. Diabetic neuropathy will be
examined using the Valk neuropathy test [32], while
hand grip strength [33,34] and the timed ‘up and go’
test will be used as measures of functional capacity [35].
To familiarize participants with the Borg scale, it will be
used during the timed ‘up and go’ and hand grip
strength tests.
The participant’s aerobic capacity will be estimated
using the sub-maximal Åstrand cycle test [36,37]. The
Åstrand cycle test will always be administered by the
physiotherapists at their own practice. Participants will
s t a r tc y c l i n ga t5 0W a t ta tap e d a lr a t eo f5 0r e v o l u t i o n s
per minute. The test will be conducted at heart rates
between 120 and maximum heart rate. The heart rates of
the fifth and sixth minutes of the test will be recorded
and used to estimate the aerobic capacity from a nomo-
gram [36]. This estimated aerobic capacity will be cor-
rected for age [38]. In addition, the rate of perceived
exertion will be recorded at each work level by means of
the Borg score, with a range of 6-20. Participants whose
heart rate cannot be used as a reference for physical fit-
ness (e.g. patients who use beta blockers) will do the
Åstrand cycle test with a Borg score between 13 and 17
[39].
Economic evaluation
The economic evaluation will compare costs and effects
of the ‘supervised exercise programme’ with those of the
‘start-up exercise programme’. The economic evaluation
will be performed from a societal perspective, which
implies that all relevant costs and outcomes will be taken
into account, regardless of who pays the costs and who
benefits from the effects. A time horizon of two years will
be used.
Both a cost-effectiveness analysis (CEA) and a cost-uti-
lity analysis (CUA) will be done. The CEA will present
clinical outcomes in terms of physical activity measured
by means of accelerometry and the short version of the
IPAQ [28]. The CUA will present effects in terms of
quality-adjusted life years (QALYs) measured by means
of the internationally developed EuroQol [40] in three-
monthly self-administered questionnaires. The QALY
incorporates multiple aspects of the intervention (e.g.
side-effects) and allows comparisons among different
(lifestyle) interventions in different target populations. A
direct value for each state of health will be generated
using social tariff, which involves an algorithm for inter-
polating EuroQol outcomes into population utilities
based on the United Kingdom valuation [41] and the
Dutch valuation [42].
Programme costs, health care costs, patient and family
c o s t sa sw e l la sl o s so fp r o d u ctivity will be assessed.
Volumes of healthcare use, loss of productivity and other
expenses will be identified by means of three-monthly
self-administered questionnaires. Cost valuation will use
the Dutch manual for cost analysis in health care research
[43], while real costs will be used otherwise. Cost prices
will be expressed in Euros from the baseline year 2011,
and otherwise indexed to the baseline year, as suggested in
the Dutch manual [44]. Because the recruitment period
will be 12 months and the follow-up period 24 months,
costs and effects in the second year of follow-up will be
discounted.
Process evaluation
A process evaluation will be used to gain insight into
reach and the attendance rates of the target population,
implementation fidelity, delivered intervention dose, and
participant perception of the intervention [45] in order
to support the interpretation of the effects. The process
evaluation will assess personal factors of participants (e.
g. self-efficacy, motivation towards being physically
active and eating healthy), self-report environmental
variables as used in the International Physical Activity
Prevalence Study (e.g. presence of pavements and per-
ceived neighbourhood safety) [46], number and duration
of the consultations with the health care providers
involved, satisfaction with the intervention contents and
feasibility of the intervention. The process will be evalu-
ated by means of self-administered questionnaires for
participants, with closed and open-ended questions. In
addition, registration forms, short surveys and semi-
structured interviews with the relevant professionals in
each practice will assess relevant barriers and facilitators
for intervention implementation. Adverse events will be
recorded.
Sample size
The intended sample size is based on the amount of
MVPA in minutes per week. An increase of 50 minutes
of MVPA per week by participants in the ‘supervised
exercise programme’, as compared to participants in the
‘start-up exercise programme’ will be considered a clini-
cally meaningful increase in MVPA. The standard devia-
tion of MVPA in this population has been reported to
be 120 minutes/week [47]. A sample size of 91 partici-
pants per condition will be needed to detect a difference
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5% significance (two-sided). Assuming a drop-out rate
of 30%, this would require 119 participants in each pro-
gramme, i.e. 238 participants in total.
Allocation to the conditions, however, will take place at
the level of GP practices, so clustering of patients within
these practices should be taken into account. Assuming
an intra-cluster correlation of 5%, and a total of 20 parti-
cipants per practice, a total sample of 24 practices (n =
480) will be needed. As practices may also drop out of
this study, we will include and allocate an additional six
practices to account for this potential drop-out. The
choice of six practices is completely arbitrary. This
results in a projected total sample of 600 participants
divided over 30 practices.
Analysis
Baseline characteristics (BMI, age, gender, amount of
MVPA by accelerometry) of both participants and clus-
ters will be analysed by means of descriptive statistics.
Statistical analyses will be performed according to the
intention-to-treat principle, while additional analyses
will be done using the per-protocol principle.
Differences between outcomes in the control and
intervention groups at different time points will be
assessed using multi-level analyses. This type of analysis
takes into account the longitudinal nature of the data,
as well as the impact of cluster randomization.
Differences in costs and effects will be presented as
incremental cost-effectiveness ratios (ICERs). ICERs repre-
sent the differences in mean costs between the experimen-
tal and control interventions in the numerator and the
difference in mean effects between the two groups in the
denominator. Sensitivity analysis will be used to assess the
robustness of the assumptions made in our base case
analysis.
Outcomes of the process evaluation will be studied by
means of descriptive statistics.
Discussion
The aim of this study is to determine whether the
‘supervised exercise programme’ of the ‘BeweegKuur’
intervention has positive effects on physical activity
levels compared to the less intensively supervised ‘start-
up exercise programme’ in a population of overweight
and obese adults with very high weight-related health
risk, and to assess the difference in costs involved
between the two lifestyle programmes. The risk of
chronic diseases is known to decrease if overweight or
obese persons achieve a more physically active lifestyle.
This might also reduce health care expenses. Therefore,
an improved lifestyle resulting from an intervention like
‘BeweegKuur’ is expected to have major positive conse-
quences at both individual and societal level.
Increasing adherence to lifestyle interventions is cru-
cial. The proposed solutions (Motivational Interviewing
and patient-specific guidance) might decrease the drop-
out rate, thereby increasing the possible effects of the
intervention and decreasing health care expenses.
Nevertheless, these solutions require extra time invest-
ment by health care providers, raising intervention
costs, so examining the cost-effectiveness of lifestyle
interventions in primary care is of great social interest.
The economic evaluation will provide insight into the
cost-effectiveness regarding the effects on quality of life
and physical activity, to support decisions concerning
insurance coverage of the ‘BeweegKuur’ intervention
and similar lifestyle interventions.
Objectively measuring physical activity levels enables
accurate conclusions to be drawn about the direct
effects of the intervention. Moreover, this will afford
new insights into physical activity and inactivity patterns
in an overweight population with very high weight-
related health risk.
This study aims to gain insight into the cost-effective-
ness of the ‘supervised exercise programme’ compared to
the ‘start-up exercise programme’, in order to inform
decision and policy makers about the implementation of
‘BeweegKuur’ in primary care in the Netherlands. In
addition, the process evaluation will provide detailed
information about the feasibility of implementing these
two interventions and the degree of satisfaction of parti-
cipants, and will also provide some insight into the
mechanisms by which the components of the interven-
tion exert their effects.
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